Idex (IEX) EBITDA (2009 - 2026)

Idex (IEX) has reported EBITDA for 18 consecutive years, with $199.9 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBITDA rose 6.39% year-over-year to $199.9 million in Q2 2026; TTM through Jun 2026 was $741.7 million, a 11.84% increase from a year earlier, with the FY2025 full-year figure at $699.3 million, up 3.26% from the prior year.
• EBITDA was $199.9 million for Q2 2026 at Idex, up from $172.4 million in the prior quarter.
• Over five years, EBITDA peaked at $202.2 million in Q3 2022 and troughed at $142.0 million in Q1 2025.
• A 5-year average of $179.6 million and a median of $183.1 million in 2024 frame the typical range for EBITDA.
• Across the five-year window, EBITDA increased 25.43% in 2022 and dropped 16.17% in 2024, its largest moves.
• Over 5 years, EBITDA stood at $175.0 million in 2022, then retreated by 8.29% to $160.5 million in 2023, then gained by 2.99% to $165.3 million in 2024, then climbed by 11.07% to $183.6 million in 2025, then grew by 8.88% to $199.9 million in 2026.
• The last three EBITDA figures came in at $199.9 million (Q2 2026), $172.4 million (Q1 2026), and $183.6 million (Q4 2025), per Business Quant data.